Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SPTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
15 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
55 filers reported a long position in SPTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARCH Venture Management, LLC | $136.6M | 6.3M | New |
| GENERAL ATLANTIC, L.P. | $132.5M | 6.1M | New |
| Sofinnova Investments, Inc. | $77.4M | 3.6M | New |
| GOLDMAN SACHS GROUP INC | $47.3M | 2.2M | New |
| TRV GP VI, LLC | $44.8M | 2.1M | New |
| CANADA PENSION PLAN INVESTMENT BOARD | $42.9M | 2M | New |
| JPMORGAN CHASE & CO | $40.9M | 1.8M | New |
| Foresite Capital Management VI LLC | $38.7M | 1.8M | New |
| PRICE T ROWE ASSOCIATES INC /MD/ | $28.4M | 1.3M | New |
| FMR LLC | $25.7M | 1.2M | New |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.